Article
Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis
25 Apr 2017
Abstract excerpt
ABSTRACT Pyrazinamide (PZA), an indispensable component of modern tuberculosis treatment, acts as a key sterilizing drug. While the mechanism of activation of this prodrug into pyrazinoic acid (POA) by Mycobacterium tuberculosis has been extensively studied, not all molecular determinants that confer resistance to this mysterious drug have been identified. Here, we report how a new PZA resistance determinant, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
